Board clears Q1 results, names new CEO and 3 Independent Directors
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 4.5 pts less than Nifty Microcap 250 and 4.1 pts less than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Board on 11 Aug 2026 approved Q1 FY27 (June 2026) results: total income 870.46 lakhs against 891.88 lakhs YoY. The company swung to a small profit of 0.28 lakhs from a loss of 74.11 lakhs a year ago. Also named Dr Thanigai Vendan Moorrthy as CEO for 5 years and appointed 3 new Independent Directors. Audit and Stakeholders Relationship Committees reconstituted.
Results show a marginal swing from loss to small profit; board strengthened with new CEO and 3 independent directors, subject to shareholder approval.